405
Views
20
CrossRef citations to date
0
Altmetric
Comprehensive Review

Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies

, , , &
Pages 780-786 | Received 07 Oct 2012, Accepted 05 Feb 2013, Published online: 13 Mar 2013

References

  • Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M. 2008. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet 33:101–6
  • An HM, Park SY, Do Kyung Lee JRK, Cha MK, Lee SW, Lim HT, Kim KJ, et al. 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 10:1–8
  • Andersson U, Bränning C, Ahrné S, Molin G, Alenfall J, Önning G, Nyman M, Holm C. 2010. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef Microb 1:189–96
  • Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg R, Moller K, Svendsen KD, Jakobsen M, Pedersen BK. 2010. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104:1831–8
  • Begley M, Hill C, Gahan CGM. 2006. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72:1729–38
  • Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. 2011. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetologica 48:257–73
  • Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli R, et al. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48:1565–75
  • Chen JJ, Wang R, Li X. 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med 236:823–31
  • D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. 2002. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324:1361--4
  • Delzenne NM, Neyrinck AM, Cani PD. 2011. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Factor 10:10--21
  • Donath MY, Shoelson SE. 2011. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107
  • Ejtahed H, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A. 2011a. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 94:3288–94
  • Ejtahed HS, Mohtadi Nia J, Homayouni Rad A, Niafar M, Asghari Jafarabadi M, Mofid V. 2011b. The effects of probiotic and conventional yoghurt on diabetes markers and insulin resistance in type 2 diabetic patients: a randomized controlled clinical trial. Iranian J Endocrinol Metabol 13:1–8
  • Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. 2012. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28:539--43
  • El Khamisy AES. 2010. Effect of Bifidobacterium and Lactobacillus acidophilus in diabetic rats. The 5th Arab and 2nd International Annual Scientific Conference; Mansoura University, Egypt
  • Fåk F, Ahrné S, Molin G, Jeppsson B, Weström B. 2008. Maternal consumption of Lactobacillus plantarum 299v affects gastrointestinal growth and function in the suckling rat. Br J Nutr 100:332–8
  • Fooks L, Gibson G. 2002. Probiotics as modulators of the gut flora. Br J Nutr 88:39–50
  • Gobel RJ, Larsen N, Jakobsen M, Molgaard C, Michaelsen KF. 2012. Probiotics to obese adolescents; RCT examining the effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 55:673--8
  • Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. 2009. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. Bmc Gastroenterology 9:15--26
  • Ilmonen J, Isolauri E, Poussa T, Laitinen K. 2011. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clin Nutr 30:156–64
  • Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, Mcquay HJ. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
  • Laitinen K, Poussa T, Isolauri E. 2009. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101:1679–87
  • Larsen N, Vogensen FK, Van Den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, et al. 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085
  • Lee J, Seto D, Bielory L. 2008. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 121:116--21
  • Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT. 2009. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 10:3755–75
  • Matsuzaki T, Nagata Y, Kado S, Kato KUI, Hashimoto S, Yokokura T. 1997a. Prevention of onset in an insdindependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Apmis 105:643--9
  • Matsuzaki T, Nagata Y, Kado S, Uchida K, Hashimoto S, Yokukura T. 1997b. Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. Apmis 105:637–42
  • Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. 1997c. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 44:357--65
  • Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, et al. 2011. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110:650--7
  • Ooi LG, Liong MT. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11:2499–522
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65
  • Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A. 2003. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67:1421--4
  • Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, Gonzalez CF, et al. 2010. Lactobacillus johnsonii N6. 2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5:e10507
  • Yadav H, Jain S, Sinha P. 2007. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23:62–8
  • Yadav H, Jain S, Sinha PR. 2008. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res 75:189–95
  • Yamano T, Tanida M, Niijima A, Maeda K, Okumura N, Fukushima Y, Nagai K. 2006. Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci 79:1963–7
  • Yun S, Park H, Kang J. 2009. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 107:1681–6
  • Zarfeshani A, Khaza’ai H, Mohd Ali R, Hambali Z, Wahle KWJ, Mutalib MSA. 2011. Effect of Lactobacillus casei on the production of pro-inflammatory markers in streptozotocin-induced diabetic rats. Probiot Antimicrob Proteins 3:168–74
  • Zhang H, Dibaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci 106:2365--70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.